199 related articles for article (PubMed ID: 33352384)
1. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.
Jiang M; Fares AF; Shepshelovich D; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Shete S; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Thomas S; Brown MC; Hung RJ; Xu W; Liu G
Lung Cancer; 2021 Feb; 152():58-65. PubMed ID: 33352384
[TBL] [Abstract][Full Text] [Related]
2. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
[TBL] [Abstract][Full Text] [Related]
3. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
4. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
5. Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies.
Sanikini H; Yuan JM; Butler LM; Koh WP; Gao YT; Steffen A; Johansson M; Vineis P; Goodman GE; Barnett MJ; Hung RJ; Chen C; Stücker I
BMC Cancer; 2018 Feb; 18(1):220. PubMed ID: 29471809
[TBL] [Abstract][Full Text] [Related]
6. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
[TBL] [Abstract][Full Text] [Related]
7. BMI-mortality association: shape independent of smoking status but different for chronic lung disease and lung cancer.
Faeh D; Kaufmann M; Haile SR; Bopp M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1851-1855. PubMed ID: 29922051
[TBL] [Abstract][Full Text] [Related]
8. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
[TBL] [Abstract][Full Text] [Related]
9. Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials.
Shukla S; Babcock Z; Pizzi L; Brunetti L
Curr Med Res Opin; 2021 May; 37(5):811-817. PubMed ID: 33685311
[TBL] [Abstract][Full Text] [Related]
10. Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysis.
Gupta A; Majumder K; Arora N; Mayo HG; Singh PP; Beg MS; Hughes R; Singh S; Johnson DH
Lung Cancer; 2016 Dec; 102():49-59. PubMed ID: 27987589
[TBL] [Abstract][Full Text] [Related]
11. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
13. A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials.
Li LX; Socinski MA; Kichenadasse G; Karapetis CS; Shahnam A; McKinnon RA; Rowland A; Hopkins AM; Sorich MJ
BMC Cancer; 2024 Mar; 24(1):379. PubMed ID: 38528478
[TBL] [Abstract][Full Text] [Related]
14. Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study.
Fukumoto K; Mori S; Shintani Y; Okami J; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Asamura H; Chida M; Date H; Endo S; Nagayasu T; Nakanishi R; Miyaoka E; Okumura M; Yoshino I;
Lung Cancer; 2020 Nov; 149():120-129. PubMed ID: 33010640
[TBL] [Abstract][Full Text] [Related]
15. Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study.
You D; Wang D; Wu Y; Chen X; Shao F; Wei Y; Zhang R; Lange T; Ma H; Xu H; Hu Z; Christiani DC; Shen H; Chen F; Zhao Y
BMC Med; 2022 Jun; 20(1):203. PubMed ID: 35658861
[TBL] [Abstract][Full Text] [Related]
16. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
17. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.
Wang C; Guo M; Zhang N; Wang G
World J Surg Oncol; 2018 May; 16(1):90. PubMed ID: 29751759
[TBL] [Abstract][Full Text] [Related]
18. The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer.
Kicken MP; Kilinc HD; Cramer-van der Welle CM; Houterman S; van den Borne BEEM; Smit AAJ; van de Garde EMW; Deenen MJ;
Cancer Treat Res Commun; 2023; 34():100676. PubMed ID: 36592497
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations.
Cortellini A; Ricciuti B; Vaz VR; Soldato D; Alessi JV; Dall'Olio FG; Banna GL; Muthuramalingam S; Chan S; Majem M; Piedra A; Lamberti G; Andrini E; Addeo A; Friedlaender A; Facchinetti F; Gorría T; Mezquita L; Hoton D; Valerie L; Nana FA; Artingstall J; Comins C; Di Maio M; Caglio A; Cave J; McKenzie H; Newsom-Davis T; Evans JS; Tiseo M; D'Alessio A; Fulgenzi CAM; Besse B; Awad MM; Pinato DJ
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35173031
[TBL] [Abstract][Full Text] [Related]
20. Increased pretreatment triglyceride glucose-body mass index associated with poor prognosis in patients with advanced non-small cell lung cancer.
Guo S; Zhao Y; Jiang Y; Ye H; Wang Y
Clin Nutr ESPEN; 2024 Feb; 59():412-421. PubMed ID: 38220404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
